Effect of Atorvastatin Usage on Patients with Oral squamous cell carcinoma
- Conditions
- Oral squamous cell carcinoma.Malignant neoplasm of mouth, unspecifiedC06.9
- Registration Number
- IRCT20230627058596N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Patients with oral squamous cell carcinoma
Lack of any other cancer except for oral squamous cell carcinoma
Not using any medication other than the ones prescribed by the surgeon
No drug interaction with atorvastatin if taken concurrently with another medication
Biopsy result of the patient indicates squamous cell carcinoma of the oral mucosa
Having similar histopathology grades
Ability to personally provide written informed consent or to understand and collaborate throughout the study
Inability or unwillingness to comply with study requirements
Patients who were previously taking statins for any reason
Treatment approach for oral squamous cell carcinoma varies due to its unique challenges
Patients undergoing treatment with anti-HIV drugs
Having a history of other cancers
Smoker patients
Patients who are consumers of a specific medication
Patients with specific systemic diseases
Patients with a history of intolerance to statins
Patients with acute liver failure
Pregnant and lactating women
consumption of another drug that interacts with atorvastatin
consumption of Gemfibrozil medication
consumption of Clarithromycin medication
consumption of Cyclosporine medication
consumption of Itraconazole medication
consumption of Colchicine medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method